Brought to you in partnership with the Multiple Myeloma Research Foundation (MMRF) Surviving one form of cancer only to be diagnosed with another can be a hard pill to swallow. In fact, it’s what happened to breast cancer survivor Evelyn read more about My Multiple Myeloma Story: “I Was Misdiagnosed 3 Times”
(HealthDay News) — Genetic tests can show which patients with the blood cancer multiple myeloma should respond to targeted therapy, a new study finds. A special six-gene pattern can help predict who is more likely to respond well to Venclexta (venetoclax), read more about Do You Have the Right Genes for This Multiple Myeloma Treatment?
Black Americans have historically been misrepresented in the medical industry, often subjected to unequal treatment and exclusion from medical advancements. This disparity is why it’s important for medical professionals, researchers, policymakers and advocates like Tony Newberne are important because these read more about Why This Multiple Myeloma Survivor Advocates for Clinical Trials
The National Institutes of Health (NIH) has launched a new clinical trial to revolutionize the treatment of acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). The myeloMATCH trial is all about finding the perfect treatment for each patient's unique cancer. read more about This Clinical Trial Wants to Test Less Toxic Treatments for Blood Cancers
